INTRODUCTION
Depression and dementia are the two most frequent psychiatric syndromes in the older adult population. Depression in older adults with and without dementia often goes unrecognized and untreated (Charney et al., 2003; Kales, Chen, Blow, Welsh, Mellow, 2005). Estimates of the prevalence of depression in older adults with dementia vary widely (Alexopoulos, Abrams, 1991; Wragg, Jeste, 1989), which is attributed to differences in sampling, diagnostic criteria used to identify depression, and the way it is assessed (Alexopoulos, Abrams, 1991; McCabe et al., 2006). Depression in older adults is not simply due to aging; medical conditions increase the likelihood of depression (Alexopoulos, 2000).
Despite expert recommendations (Alexopoulos et al., 2001) and increased availability of a range of depression treatment options (e.g., medication, psychotherapy, combination therapy, and ECT), depression remains a significant public health problem for older adults (Surgeon General Healthy People 2010). Detection is the first essential step to improving depression care for patients with dementia.
Major depression is a syndrome characterized by a number of signs and symptoms. According to the DSM-IV TR (American Psychiatric Association, 2000), at least five symptoms must be present for a diagnosis of major depression to be made (see Definitions of Key terms). In a study conducted in a nursing home, 25% of residents screened positive for major depression (Gruber-Baldini et al., 2005). This is close to the prevalence rate of major depression reported for persons with Alzheimer’s disease (Alexopoulos, Abrams, 1991 [15%–20%]; Lyketsos et al., 1997 [22%]; Wragg, Jeste, 1989 [10%–20%]). In recognition that many demented patients experience clinically significant depression that may not meet full criteria for major depression, Olin et al. (2002b) have proposed new provisional diagnostic criteria for depression of Alzheimer disease. Diagnostic criteria include fewer symptoms of depression (three symptoms versus five symptoms required for major depression). In addition, symptoms need to be present for a shorter period of time due to the fluctuating nature of depression in persons with dementia (Abrams, Alexopoulos, 1994; Jost, Grossberg, 1996). However, research studies are still needed to validate these new depression criteria (Charney et al., 2003).
Depression screening in persons with dementia is hindered at times by the patient’s inability to self-report symptoms and tendency to underestimate degree of depression, and discrepant caregiver reports (Teri, Wagner, 1991). The assessment of depression in dementia is complicated by the considerable overlap in its clinical presentation with that of dementia.
PURPOSE
The purpose of this evidence-based guideline is to improve detection of depression in older adults with dementia. This guideline may be used by physicians, advanced practice nurses, registered nurses, licensed practical nurses, and social workers across a variety of settings including inpatient and outpatient, long-term care, assisted living, and home care.
INDIVIDUALS/PATIENTS AT RISK FOR DEPRESSION
The following characteristics increase the risk of major depression (APA, 2000).
A prior episode of major depression
Severe psychosocial events (stressors), such as death of a loved one, marital separation, divorce
Chronic general medical conditions
Substance dependence issues
A family history of depressive disorders
Being female
Loss of independent functioning (Rovner, Ganguli, 1998)
Acutely disabling conditions (e.g., stroke, MI) (Alexopoulos et al., 1997; Lesprance, Frasure-Smith, Talajic, 1996)
Physical disability (Bruce, Seeman, Merrill, Blazer, 1994)
ASSESSMENT CRITERIA
Any individual over age 60 should be screened for depression periodically. The AGS recommends depression screening two to four weeks after admission to a nursing home and then repeated screening at least every six months after admission. In all nursing homes, residents should be screened at least every six months (AGS & AAGP, 2003; Snowden et al., 2003).
DESCRIPTION OF THE PRACTICE
The following assessment is a three-step procedure that can be used across health care settings to screen for the presence of depressive symptoms. This is a screening guideline, not a diagnostic process. Positive screens should be followed with a diagnostic evaluation by a skilled health care provider.
Implementation of the evidence-based guideline requires administration of the Mini-Mental State Exam (MMSE) (Folstein, Folstein, McHugh, 1975), and either the Geriatric Depression Scale Short Form (SGDS) (Sheik, Yesavage, 1986) or the Cornell Scale for Depression in Dementia (CSDD) (Alexopoulos, Abrams, Young, Shamoian, 1988) depending on level of cognitive functioning. The Mini-Mental State Exam is a widely used cognitive functioning assessment that screens for dementia. Its short, ten-minute administration allows the administrator to quickly screen for cognitive deficits.
The Geriatric Depression Scale (GDS) is a depression screening tool that takes about five minutes to administer and has been validated for community-dwelling, hospitalized, and institutionalized older adults (Koenig, Meador, Cohen, Blazer, 1988; Lesher, Berryhill, 1994; Sheik, Yesavage, 1986). The Cornell Scale for Depression in Dementia is a depression severity tool that can also be utilized for screening. The tool has been validated to rate depressive symptomalogy over the entire range of cognitive impairment (Alexopoulos et al., 1988).
In order to implement this guideline, we first suggest that a series of five patients be assessed by the user with the supervision of a mental health expert (Cohen, Hyland, Kimhy, 2003; Schnelle, Wood, Schnelle, Simmons, 2001; Teresi, Abrams, Holmes, Ramirez, Eimicke, 2001).
Step 1: MMSE (Mini Mental State Exam; Folstein et al., 1975): Assess for cognitive impairment using the Mini-Mental State Exam (MMSE)
If the patient scores 24 or above, you may need to refer to the RTDC guideline Detection of Depression in the Cognitively Intact Older Adult (Piven, 2005).
If the patient scores below 24 on the MMSE, establish whether this reflects an acute change in mental status or rather the patient’s baseline cognitive function or expected progressive mental status changes associated with Alzheimer’s disease and other forms of dementia. An acute change in cognition requires immediate medical attention.
If score reflects baseline cognitive function or expected progressive mental status changes, continue with Step 2.
Step 2: Depression Screen
Depression screening can be conducted at various periods during a standard assessment. Particularly good opportunities present themselves after assessment of functional status, the experience of pain, or use of coping strategies.
If the patient scores 15 to 23 on the MMSE, administer the Short Form of the Geriatric Depression Scale (SGDS) (McCabe et al., 2006; Lesher, Berryhill, 1994; Sheik, Yesavage, 1986).
If the patient scores below 15 on the MMSE, administer the Cornell Scale for Depression in Dementia (CSDD) (Alexopoulos et al., 1988).
Because many patients with dementia may be unable to reliably report emotional symptoms, the CSDD derives information from interviews with both the patient and an informant. This approach is consistent with the DSM-IV TR (APA, 2000) where all sources of information are used as necessary to make a clinical judgment. Research has confirmed the value of informant reports of symptoms of depression when assessing older adult patients (McAvay, Bruce, Raue, Brown, 2004). The informant should be a close family member or other individual who knows and has frequent contact with the patient (e.g., nurse, social worker, home health aide) (Alexopoulos, 2002).
Step 3: Referral Referral of positive screens
For SGDS scores of 6 or greater, notify primary health care provider of immediate need for further evaluation, treatment, or referral for clinically significant depression (i.e., probable or definite major depression).
For CSDD scores of 11 or greater, notify primary health care provider of immediate need for further evaluation, treatment, or referral for clinically significant depression (i.e., probable or definite major depression).
Procedure for negative screens
For SGDS scores below 6, reassess individual in one month if clinically indicated. If not, perform screening process in six months.
For CSDD scores below 11, reassess individual in one month if clinically indicated. If not, perform screening process in six months.
Outcome Indicators
Outcome indicators are those expected to change or improve from consistent use of the guideline. The major outcome indicators that should be monitored over time are:
Increasing percentage of patients receiving a mental health referral for depression (Callahan et al., 2006).
Increasing recognition of depression symptoms in patients with dementia (Cohen et al., 2003).
Improved detection, treatment, and course of depression in normal practice (Eisses et al., 2005)
FIGURE 1.
ALGORITHM FOR DETECTION OF DEPRESSION IN OLDER ADULTS WITH DEMENTIA POPULATION
TABLE 1.
DEFINITION OF KEY TERMS
ALZHEIMER’S DISEASE – A cortical degenerative disease. Essential features include: memory impairment, impairment in at least one other cognitive domain (e.g., language and visual-spatial skills), and significant disturbance in work or social functioning resulting from cognitive deficits (Small, 2000). |
ANHEDONIA – A pervasive loss of interest or ability to experience pleasure in normally enjoyable activities. |
ANTIDEPRESSANT MEDICATION – A class of medication that is used to treat depression by restoring the balance of neurotransmitters in the brain. |
APATHY – A loss of motivation manifesting itself in behaviors such as diminished initiation, poor persistence, lowered interest, indifference, low social engagement, blunted emotional response, and lack of insight (Landes, Sperry, Strauss, Geldmacher, 2001). |
DEMENTIA – Multiple cognitive deficits that include impairment in memory and at least one other cognitive disturbance (i.e., aphasia, agnosia, or a disturbance in executive functioning) whose severity impairs social or occupational functioning. The course is characterized by gradual onset and continuing cognitive decline. (APA, 2000). |
DEPRESSED MOOD – A pervasive feeling of sadness. |
DIMINISHED INTEREST IN ACTIVITIES – See Anhedonia. |
DSM-IV (Diagnostic and Statistical Manual of Mental Disorders, American Psychiatric Association, 2000: Fourth Edition, Text Revision) – A manual of diagnostic criteria that is commonly used by mental health professionals to assign specific psychiatric diagnoses; it is also integrated into the ICD-10. |
MDD (Major Depressive Disorder) – According to DSM-IV, MDD is a clinical syndrome that includes five (or more) of the following symptoms that have been present during the same two week period and represent a change from previous functioning (APA, 2000); at least one of the symptoms must be DEPRESSED MOOD or ANHEDONIA and |
Significant weight loss or gain (e.g., a change of more than 5% of body weight in a month or decrease or increase in appetite nearly every day) |
Insomnia or hypersomnia nearly every day |
Psychomotor agitation or retardation nearly every day |
Fatigue or loss of energy nearly every day |
Feelings of worthlessness or excessive or inappropriate guilt nearly every day |
Diminished ability to think or concentrate or indecisiveness, nearly every day |
Recurrent thoughts of death, recurrent suicidal ideation without a specific plan, or a suicide attempt or specific plan for committing suicide |
PSYCHOTHERAPY – A psychological method of treating mental or emotional disorders based on the patient therapist relationship. |
PSYCHOTROPIC MEDICATIONS – Pharmacological agents used to treat psychiatric disorders. |
SOCIAL ISOLATION – Withdrawal from social contacts and customary activities (Olin, Katz, Meyers, Schneider, Lebowitz, 2002a). |
STIGMA – A mark of disgrace; a stain or reproach, as on one’s reputation. |
Acknowledgments
Guidelines in this series were produced with support provided by Grant #P30 NR03979 [PI: Toni Tripp-Reimer, The University of Iowa College of Nursing], National Institute of Nursing Research, NIH.
Contributor Information
Ellen L. Brown, Email: ebrown@fiu.edu, Florida International University, College of Nursing and Health Sciences, University Park, ACH-C 226, 11200 S.E. 8th Street, Miami, Florida 33199, (305)348-1312.
Patrick Raue, Weill Medical College of Cornell University.
Susan Adams, Research Translation and Dissemination Core, Gerontological Nursing Interventions Research Center, The University Iowa College of Nursing, Iowa City, Iowa.
Marita G. Titler, Research, Quality and Outcomes Management, Department of Nursing Services, and Patient Care, University of Iowa Hospitals and Clinics and Director, Research Translation and Dissemination Core, Gerontological Nursing Interventions Research Center, The University Iowa College of Nursing, Iowa City, Iowa.
References
- Abrams RC, Alexopoulos GS. Assessment of Depression in Dementia. Alzheimer Disease and Associated Disorders. 1994;8(Suppl 1):S227–9. [PubMed] [Google Scholar]
- Alexopoulos G. Mood Disorders. In: Sadock BJ, Sadock VA, editors. Kaplan & Sadock’s Comprehensive Textbook of Psychiatry. 2. II. Philadelphia: Lippincott Williams & Wilkins; 2000. pp. 3060–3068. [Google Scholar]
- Alexopoulos GS. Unpublished manuscript. Cornell Institute of Geriatric Psychiatry, Weill Medical College of Cornell University; 2002. The Cornell Scale for Depression in Dementia: Administration and Scoring Guidelines. [Google Scholar]
- Alexopoulos GS, Abrams RC. Depression in Alzheimer’s disease. The Psychiatric Clinics of North America. 1991;14:327–340. [PubMed] [Google Scholar]
- Alexopoulos GS, Abrams RC, Young RC, Shamoian CA. Cornell Scale for Depression in Dementia. Biological Psychiatry. 1988;23:271–84. doi: 10.1016/0006-3223(88)90038-8. [DOI] [PubMed] [Google Scholar]
- Alexopoulos GS, Katz IR, Reynolds CF, 3rd, Carpenter D, Docherty JP, Ross RW. Pharmacotherapy of depression in older patients: a summary of the expert consensus guidelines. Journal of Psychiatric Practice. 2001;7(6):361–376. doi: 10.1097/00131746-200111000-00003. [DOI] [PubMed] [Google Scholar]
- Alexopoulos GS, Meyers BS, Young RC, Campbell S, Silbersweig D, Charlson M. ‘Vascular Depression’ Hypothesis. Archives of General Psychiatry. 1997;54(10):915–922. doi: 10.1001/archpsyc.1997.01830220033006. [DOI] [PubMed] [Google Scholar]
- American Geriatrics Society [AGS] and American Association for Geriatric Psychiatry [AAGP] Consensus Statement on Improving the Quality of Mental Health Care in U.S. Management of Depression and Behavioral Symptoms Associated with Dementia. JAGS. 2003;51:1287–1298. doi: 10.1046/j.1532-5415.2003.51415.x. [DOI] [PubMed] [Google Scholar]
- American Psychiatric Association [APA] Diagnostic and Statistical Manual of Mental Disorders. 4. Washington, DC: American Psychiatric Association; 2000. Text Revision. [Google Scholar]
- Bruce ML, Seeman TE, Merrill SS, Blazer DG. The Impact of Depressive symptomatology on Physical Disability: MacArthur Studies on Successful Aging. American Journal of Public Health. 1994;84:1796–1799. doi: 10.2105/ajph.84.11.1796. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Callahan C, Boustani M, Unverzagt F, Austrom M, Damush T, Perkins A, Fultz B, Hui S, Counsell S, Hendrie H. Effectiveness of Collaborative Care for Older Adults with AD in Primary Care. JAMA. 2006;295(18):2148–2157. doi: 10.1001/jama.295.18.2148. [DOI] [PubMed] [Google Scholar]
- Charney DS, Reynolds CF, 3rd, Lewis L, Lebowitz BD, Sunderland T, Alexopoulos GS, Blazer DG, Katz IR, Meyers BS, Arean PA, Borson S, Brown C, Bruce ML, Callahan CM, Charlson ME, Conwell Y, Cuthbert BN, Devanand DP, Gibson MJ, Gottlieb GL, Krishnan KR, Laden SK, Lyketsos CG, Mulsant BH, Niederehe G, Olin JT, Oslin DW, Pearson J, Persky T, Pollock BG, Raetzman S, Reynolds M, Salzman C, Schulz R, Schwenk TL, Scolnick E, Unutzer J, Weissman MM, Young RC Depression Bipolar Support Alliance. Depression and Bipolar Support Alliance consensus statement on the unmet needs in diagnosis and treatment of mood disorders in late life. Archives of General Psychiatry. 2003;60(7):664–72. doi: 10.1001/archpsyc.60.7.664. [DOI] [PubMed] [Google Scholar]
- Cohen CI, Hyland K, Kimhy D. The Utility of Mandatory Depression Screening of Dementia Patients in Nursing Homes. American Journal of Psychiatry. 2003;160(11):2012–7. doi: 10.1176/appi.ajp.160.11.2012. [DOI] [PubMed] [Google Scholar]
- Eisses AMH, Kluiter H, Jongenelis K, Pot AM, Beekman ATF, Ormel J. Care Staff Training in Detection of Depression in Residential Homes for the Elderly. The British Journal of Psychiatry. 2005;186:404–409. doi: 10.1192/bjp.186.5.404. [DOI] [PubMed] [Google Scholar]
- Folstein MF, Folstein SE, McHugh PR. Mini-Mental state. A Practical Method for Grading the Cognitive State of Patients for the Clinician. Journal of Psychiatric Research. 1975;12(3):189–98. doi: 10.1016/0022-3956(75)90026-6. [DOI] [PubMed] [Google Scholar]
- Gruber-Baldini AL, Zimmerman S, Boustani M, Watson LC, Williams CS, Reed PS. Characteristics Associated with Depression in Long-Term Care Residents with Dementia. The Gerontologist. 2005;45(Special Issue I):50–55. doi: 10.1093/geront/45.suppl_1.50. [DOI] [PubMed] [Google Scholar]
- Jost BC, Grossberg GT. The Evolution of Psychiatric Symptoms in Alzheimer’s Disease; A Natural History Study. Journal of American Geriatrics Society. 1996;44:1078–1081. doi: 10.1111/j.1532-5415.1996.tb02942.x. [DOI] [PubMed] [Google Scholar]
- Kales H, Chen P, Blow F, Welsh D, Mellow A. Rates of Clinical Depression Diagnosis, Functional Impairment and Nursing Home Placement in Coexisting Dementia and Depression. American Journal of Geriatric Psychiatry. 2005;13(5):441–449. doi: 10.1176/appi.ajgp.13.6.441. [DOI] [PubMed] [Google Scholar]
- Koenig HG, Meador KG, Cohen HJ, Blazer DG. Self-Rated Depression Scales and Screening for Major Depression in the Older Hospitalized Patient with Medical Illness. Journal of American Geriatrics Society. 1988;36:699–706. doi: 10.1111/j.1532-5415.1988.tb07171.x. [DOI] [PubMed] [Google Scholar]
- Landes AM, Sperry SD, Strauss ME, Geldmacher DS. Apathy in Alzheimer’s Disease. Journal of American Geriatrics Society. 2001;49:1700–1707. doi: 10.1046/j.1532-5415.2001.49282.x. [DOI] [PubMed] [Google Scholar]
- Lesher EL, Berryhill JS. Validation of the Geriatric Depression Scale—Short Form among Inpatient. Journal of Clinical Psychology. 1994;50(2):256–60. doi: 10.1002/1097-4679(199403)50:2<256::aid-jclp2270500218>3.0.co;2-e. [DOI] [PubMed] [Google Scholar]
- Lesprance F, Frasure-Smith N, Talajic M. Major Depression Before and After Myocardial Infarction: Its Nature and Consequence. Psychosomatic Medicine. 1996;58:99–110. doi: 10.1097/00006842-199603000-00001. [DOI] [PubMed] [Google Scholar]
- Lyketsos CG, Steele C, Baker L, Galik E, Kopunek S, Steinberg M, Warren A. Major and Minor Depression in Alzheimer’s Disease: Prevalence and Impact. Journal of Neuropsychiatry and Clinical Neurosciences. 1997;9:556–561. doi: 10.1176/jnp.9.4.556. [DOI] [PubMed] [Google Scholar]
- McAvay GJ, Bruce ML, Raue PJ, Brown EL. †Depression in elderly homecare patients: Patient versus†informant reports. Psychological Medicine. 2004;34:1507–1516. doi: 10.1017/s0033291704002582. [DOI] [PubMed] [Google Scholar]
- McCabe MP, Davison T, Mellor D, George K, Moore K, Ski C. Depression among Older People with Cognitive Impartment: Prevalence and Detection. International Journal of Geriatric Psychiatry. 2006;21:633–644. doi: 10.1002/gps.1538. [DOI] [PubMed] [Google Scholar]
- Olin JT, Katz IR, Meyers BS, Schneider LS, Lebowitz BD. Provisional Diagnostic Criteria for Depression of Alzheimer’s Disease. American Journal of Geriatric Psychiatry. 2002a;10:129–141. [PubMed] [Google Scholar]
- Olin JT, Schneider LS, Katz IR, Meyers BS, Alexopoulos GS, Breitner JC, Bruce ML, Caine ED, Cummings JL, Devanland DP, Krishnan KRR, Lyketsos CG, Lyness JM, Rabins PV, Reynolds CF, III, Rovner BW, Steffens DC, Tariot PN, Lebowitz BD. Provisional Diagnostic Criteria for Depression of Alzheimer’s Disease. American Journal of Geriatric Psychiatry. 2002b;10:125–128. [PubMed] [Google Scholar]
- Piven MLS. Detection of Depression in the Cognitively Intact Older Adult. In: Titler MG, editor. Series on Evidence-Based Practice for Older Adults. Iowa City: The University of Iowa Gerontological Nursing Interventions Research Center, Research Translation and Dissemination; 2005. [Google Scholar]
- Rovner BW, Ganguli M. Depression and Disability Associated with Impaired Vision: The MoVies Project. Journal of American Geriatric Society. 1998;46:617–619. doi: 10.1111/j.1532-5415.1998.tb01080.x. [DOI] [PubMed] [Google Scholar]
- Schnelle JF, Wood S, Schnelle ER, Simmons SF. Measurement Sensitivity and the Minimum Data Set Depression Quality Indicator. Gerontologist. 2001;41(3):401–405. doi: 10.1093/geront/41.3.401. [DOI] [PubMed] [Google Scholar]
- Sheikh JI, Yesavage JA. Clinical Gerontology: A Guide to Assessment and Intervention. NY: The Haworth Press; 1986. Geriatric Depression Scale (GDS): Recent Evidence and Development of a Shorter Version; pp. 165–173. [Google Scholar]
- Small G. Alzheimer’s Disease and Other Dementias. In: Sadock BJ, Sadock VA, editors. Kaplan & Sadock’s Comprehensive Textbook of Psychiatry. 2. II. Philadelphia: Lippincott Williams & Wilkins; 2000. pp. 3068–3073. [Google Scholar]
- Snowden M, Sato K, Roy-Byrne P. Assessment and Treatment of Nursing Home Residents with Depression or Behavioral Symptoms Associated with Dementia: A Review of the Literature. Journal of American Geriatrics Society. 2003;51:1305–1317. doi: 10.1046/j.1532-5415.2003.51417.x. [DOI] [PubMed] [Google Scholar]
- Surgeon General Healthy People. 2010 Retrieved December 18, 2006 from http://www.healthypeople.gov/LHI/lhiwhat.htm.
- Wragg RE, Jeste DV. Overview of Depression and Psychosis in Alzheimer’s Disease. American Journal of Psychiatry. 1989;145 (5):577–587. doi: 10.1176/ajp.146.5.577. [DOI] [PubMed] [Google Scholar]
- Teresi J, Abrams R, Holmes D, Ramirez M, Eimicke J. Prevalence of Depression and Depression Recognition in Nursing Homes. Social Psychiatry and Psychiatric Epidemiology. 2001;36:613–620. doi: 10.1007/s127-001-8202-7. [DOI] [PubMed] [Google Scholar]
- Teri L, Wagner A. Assessment of Depression in Patients with Alzheimer’s Disease: Concordance among Informants. Psychology and Aging. 1991;6(2):280–285. doi: 10.1037//0882-7974.6.2.280. [DOI] [PubMed] [Google Scholar]